Bullish
PYXS: Mid-year data will clarify MICVO's efficacy, safety, and pivotal trial path in head and neck cancer
Pyxis Oncology (PYXS) is developing a novel ADC called MICVO for head and neck cancer. Mid-year data is expected to provide clarity on its efficacy, s...